NTLA Operating Cash Flow (Statement)
Intellia Therapeutics Inc · Operating Cash Flow (Statement)
NTLA Operating Cash Flow (Statement)
Latest reported-$83.11Mperiod ending
NTLA Quarterly Cash from Operations (-$4.00K → -$83.11M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
NTLA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -83,113,000 | |
| -117,346,000 | |
| -69,285,000 | |
| -76,899,000 | |
| -99,622,000 | |
| -148,930,000 | |
| -85,195,000 | |
| -84,837,000 | |
| -58,186,000 | |
| -120,662,000 | |
| -93,054,000 | |
| -101,381,000 | |
| -90,323,000 | |
| -109,328,000 | |
| -89,869,000 | |
| -78,526,000 | |
| -85,091,000 | |
| -79,801,000 | |
| -54,651,000 | |
| -65,022,000 | |
| -52,981,000 | |
| -52,376,000 | |
| -40,226,000 | |
| -28,558,000 | |
| 57,417,000 | |
| -38,545,000 | |
| -28,662,000 | |
| -25,448,000 | |
| -27,677,000 | |
| -21,453,000 | |
| -8,538,000 | |
| -12,454,000 | |
| -22,495,000 | |
| -17,770,000 | |
| -21,306,000 | |
| -16,894,000 | |
| -15,678,000 | |
| -11,398,000 | |
| -14,410,000 | |
| -7,610,000 | |
| 67,550,000 | |
| -9,421,000 | |
| -5,491,000 | |
| -3,267,000 | |
| 2,173,000 | |
| 4,822,000 | |
| -2,734,000 | |
| -4,000 |